BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8912085)

  • 1. Hurthle cell tumor.
    Chen HY; Benjamin LB; Chen MF
    Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral lobectomy for Hurthle cell adenoma.
    Wasvary H; Czako P; Poulik J; Lucas R
    Am Surg; 1998 Aug; 64(8):729-32; discussion 732-3. PubMed ID: 9697901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hürthle cell tumors of the thyroid gland.
    Heppe H; Armin A; Calandra DB; Lawrence AM; Paloyan E
    Surgery; 1985 Dec; 98(6):1162-5. PubMed ID: 4071391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience in Hurthle cell tumors].
    Francomano F; Napolitano L; Scipione P; Savini F; Bajocchi G; Angelucci D
    G Chir; 1998; 19(11-12):449-52. PubMed ID: 9882947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hürthle cell tumors of the thyroid gland. Personal experience and review of literature.
    Bononi M; De Cesare A; Cangemi V; Fiori E; Galati G; Giovagnoli MR; Izzo L; Cimitan A; Meucci M; Cavallaro A
    Anticancer Res; 2002; 22(6B):3579-82. PubMed ID: 12552959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hürthle cell tumors: applying molecular markers to define a new management algorithm.
    Maxwell EL; Palme CE; Freeman J
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):54-8. PubMed ID: 16415430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hürthle cell tumor of the thyroid gland. Analysis of a series of 33 cases].
    Janser JC; Pusel J; Rodier JF; Navarrete E; Rodier D
    J Chir (Paris); 1989 Nov; 126(11):619-24. PubMed ID: 2685000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hürthle-cell thyroid neoplasms: a clinical enigma].
    Cannizzaro M; Fiorenza G; Garofalo L; De Maria A; Cavallaro N; Pulvirenti A; Veroux PF
    Ann Ital Chir; 1999; 70(4):503-8; discussion 508-9. PubMed ID: 10573612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hürthle cell lesions in thyroid neoplasms.
    Khan MS; al-Manee MS; Huzaimeh IA; Ahmad MS
    Int Surg; 1989; 74(4):261-6. PubMed ID: 2625402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for thyroid Hürthle cell tumours--a single institution experience.
    Paunovic I; Krgovic K; Tatic S; Diklic A; Zivaljevic V; Kalezic N; Havelka M
    Eur J Surg Oncol; 2006 May; 32(4):458-61. PubMed ID: 16497473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hürthle cell tumors: personal experience].
    De Toma G; Gabriele R; Sgarzini G; Plocco M; Campli M; Sambuco L
    G Chir; 1995 May; 16(5):223-6. PubMed ID: 7654499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hürthle cell carcinoma of the thyroid. A 41 years experience].
    Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V
    Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.